Beclometasone inhaler-induced recovery of refractory peri-ileostomy skin complications. (23rd March 2023)

• Record Type: Journal Article
• Authors: McDonald, Mary; Connelly, Tara M; Brett, Aishling; McCullough, Peter; Cooke, Fiachra; Neary, Peter
• Is Part Of: British journal of nursing. Volume 32:Number 6(2023)
• Page Start: S16
• Page End: S26
• Publication Date: 2023-03-23
• Subjects: Beclometasone -- Stoma -- Moisture-associated skin damage -- Medical adhesive-related skin injury -- Stoma -- Ileostomy -- Peristomal skin; Nursing -- Periodicals; 610.73
• DOI: 10.12968/bjon.2023.32.6.S16
• Languages: English
• ISSNs: 0966-0461

Abstract

Abstract : Peristomal skin complications (PSCs) are relatively common in ostomy patients, particularly in those with ileostomies. Non-healing irritation presents a clinical challenge and leads to pain and impaired quality of life for patients. Methods: The cases of four ileostomy patients experiencing severe, challenging PSCs refractory to appliance changes, conventional dressings and barrier creams are discussed. Findings: The cases of one male and one female patient with an end ileostomy post-subtotal colectomy for ulcerative colitis, one female with a defunctioning ileostomy post-anterior resection for sigmoid carcinoma and one male with an end ileostomy with a complex Crohn's surgical history are described. Two puffs of a 250 mcg metered dose beclometasone inhaler were applied to the affected skin once or twice daily. Treatment ranged from 6 to 21 days. Complete resolution was seen in all cases. Conclusion: Topical use of a beclometasone inhaler was effective for severe peri-ileostomy PSC secondary to four different aetiologies. Further studies are warranted to determine the effectiveness of this treatment in a larger patient cohort.